Literature DB >> 12578468

FDA orders estrogen safety warnings: agency offers guidance for HRT use.

Joan Stephenson.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12578468     DOI： 10.1001/jama.289.5.537

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  [Evidence based basis of decision making for or against a postmenopausal hormone treatment].

Authors:  Eva Rásky
Journal:  Wien Klin Wochenschr       Date:  2004-07-31       Impact factor: 1.704

2.  Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.

Authors:  Susan L Lakey; Susan D Reed; Andrea Z LaCroix; Lou Grothaus; Katherine M Newton
Journal:  J Womens Health (Larchmt)       Date:  2010-11-09       Impact factor: 2.681

3.  Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort study.

Authors:  Satabdi Chatterjee; Hua Chen; Michael L Johnson; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2012-10       Impact factor: 3.923

4.  What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy.

Authors:  Danielle Campfield Bonadies; Anne Moyer; Ellen T Matloff
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

Review 5.  Chemotherapy-induced ovarian failure: manifestations and management.

Authors:  Julian R Molina; Debra L Barton; Charles L Loprinzi
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  The current state of postmenopausal hormone therapy: update for neurologists and epileptologists.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

Review 7.  Cathepsin K inhibitors for osteoporosis and potential off-target effects.

Authors:  Dieter Brömme; Fabien Lecaille
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

8.  Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events.

Authors:  Jacqueline Suk Danik; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

Review 9.  The aging spine: new technologies and therapeutics for the osteoporotic spine.

Authors:  Joseph M Lane; Michael J Gardner; Julie T Lin; Marjolein C van der Meulen; Elizabeth Myers
Journal:  Eur Spine J       Date:  2003-10-08       Impact factor: 3.134

10.  Antiosteoporotic Activity of Dioscorea alata L. cv. Phyto through Driving Mesenchymal Stem Cells Differentiation for Bone Formation.

Authors:  Kang-Yung Peng; Lin-Yea Horng; Hui-Ching Sung; Hui-Chuan Huang; Rong-Tsun Wu
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-29       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.